Giant-cell tumor of bone: treatment options and role of denosumab

References

• FletcherCDUnniKKMertensFPathology and Genetics of Tumours of Soft Tissue and BoneLyonInternational Agency for Research on Cancer2002
   Google Scholar
• ThomasDMRANKL, denosumab, and giant cell tumor of boneCurr Opin Oncol201224439740322581354
   PubMed Web of Science ®Google Scholar
• LaceyDLBoyleWJSimonetWSBench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabNat Rev Drug Discov201211540141922543469
   PubMed Web of Science ®Google Scholar
• CampanacciMBaldiniNBorianiSSudaneseAGiant-cell tumor of boneJ Bone Joint Surg Am19876911061143805057
   PubMed Web of Science ®Google Scholar
• SkubitzKThomasDChawlaSStaddonAResponse to treatment with denosumab in patients with giant cell tumor of bone (GCTB): FDG PET results from two phase 2 trialsJ Clin Oncol2014325 Suppl10505
   Web of Science ®Google Scholar
• CowanRWSinghGGiant cell tumor of bone: a basic science perspectiveBone201352123824623063845
   PubMed Web of Science ®Google Scholar
• ByersVSLevinASJohnstonJOHackettAJQuantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcomaCancer Res1975359252025311097109
   PubMed Web of Science ®Google Scholar
• GoldringSRRoelkeMSPetrisonKKBhanAKHuman giant cell tumors of bone identification and characterization of cell typesJ Clin Invest19877924834913027126
   PubMed Web of Science ®Google Scholar
• WüllingMDellingGKaiserEThe origin of the neoplastic stromal cell in giant cell tumor of boneHum Pathol2003341098399314608531
   PubMed Web of Science ®Google Scholar
• BardiGPandisNMandahlNChromosomal abnormalities in giant cell tumors of boneCancer Genet Cytogenet19915721611671756493
   PubMedGoogle Scholar
• BridgeJAMouronBJNeffJRBhatiaPSSignificance of chromosomal abnormalities in a malignant giant cell tumor of boneCancer Genet Cytogenet199157187921756489
   PubMedGoogle Scholar
• BridgeJANeffJRBhatiaPSSangerWGMurpheyMDCytogenetic findings and biologic behavior of giant cell tumors of boneCancer19906512269727032340469
   PubMed Web of Science ®Google Scholar
• AndersonDMMaraskovskyEBillingsleyWLA homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature199739066561751799367155
   PubMed Web of Science ®Google Scholar
• CowanRWSinghGGhertMPTHrP increases RANKL expression by stromal cells from giant cell tumor of boneJ Orthop Res201230687788422102368
   PubMed Web of Science ®Google Scholar
• KiviojaAHBlomqvistCHietaniemiKCement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 yearsActa Orthop2008791869318283578
   PubMed Web of Science ®Google Scholar
• FeigenbergSJMarcusRBJrZloteckiRAScarboroughMTBerreyBHEnnekingWFRadiation therapy for giant cell tumors of boneClin Orthop Relat Res200341120721612782877
   PubMed Web of Science ®Google Scholar
• RukaWRutkowskiPMorysińskiTThe megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of boneInt J Radiat Oncol Biol Phys201078249449820004531
   PubMed Web of Science ®Google Scholar
• BucayNSarosiIDunstanCROsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationGenes Dev1998129126012689573043
   PubMed Web of Science ®Google Scholar
• RockMGSimFHUnniKKSecondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patientsJ Bone Joint Surg Am1986687107310793745247
   PubMed Web of Science ®Google Scholar
• LinPPGuzelVBMouraMFLong-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolizationCancer20029561317132512216101
   PubMed Web of Science ®Google Scholar
• BalkeMCampanacciLGebertCBisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of boneBMC Cancer20101046220799989
   PubMed Web of Science ®Google Scholar
• ChengYYHuangLLeeKMXuJKZhengMHKumtaSMBisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of boneCalcif Tissue Int2004751717715037971
   PubMed Web of Science ®Google Scholar
• ThomasDHenshawRSkubitzKDenosumab in patients with giant-cell tumour of bone: an open-label, phase 2 studyLancet Oncol201011327528020149736
   PubMed Web of Science ®Google Scholar
• BranstetterDGNelsonSDManivelJCDenosumab induces tumor reduction and bone formation in patients with giant-cell tumor of boneClin Cancer Res201218164415442422711702
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA approves Xgeva to treat giant cell tumor of the bone2013 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm356528.htmAccessed May 5, 2015
   Google Scholar
• ChawlaSHenshawRSeegerLSafety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studyLancet Oncol201314990190823867211
   PubMed Web of Science ®Google Scholar
• KarrasNAPolgreenLEOgilvieCManivelJCSkubitzKMLipsitzEDenosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girlJ Clin Oncol20133112e200e20223509309
   PubMed Web of Science ®Google Scholar
• GeorgeSMerriamPMakiRGMulticenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomasJ Clin Oncol200927193154316019451429
   PubMed Web of Science ®Google Scholar
• TseLFWongKCKumtaSMHuangLChowTCGriffithJFBisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control studyBone12008421687317962092
   PubMed Web of Science ®Google Scholar
• GouinFRochwergerARDi MarcoAAdjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of boneEur J Cancer201450142425243125088085
   PubMed Web of Science ®Google Scholar
• Martin-BrotoJCleelandCSGlarePAEffects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II studyActa Oncol20145391173117924834795
   PubMed Web of Science ®Google Scholar